Lataa...
Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
The LSL-Kras(G12D/+); LSL-Trp53(R172H/+); Pdx-1-Cre (KPC) mouse model represents an established and frequently used transgenic model to evaluate novel therapies in pancreatic cancer. Tumor onset is variable in the KPC model between 8 weeks and several months. Therefore, non-invasive imaging tools ar...
Tallennettuna:
| Julkaisussa: | J Vis Exp |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MyJove Corporation
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933419/ https://ncbi.nlm.nih.gov/pubmed/29683461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3791/56979 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|